TSG-01
Phase 2- Indications
- Chronic heart failure
Company intelligence / Profile preview
Shanghai Hongyitang Biopharmaceutical Technology
Shanghai*, Shanghai, Chinaprnewswire.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Shanghai Hongyitang Biopharmaceutical Technology is a Chinese biotech/pharma company focused on developing therapies for chronic heart failure. It has been cited among key players with ongoing clinical programs addressing unmet needs in cardiovascular disease. Specific details about its lead assets or clinical results are limited in public English-language databases, but its inclusion alongside major pharma companies suggests credible R&D activity targeting novel mechanisms or modalities within the field.
- Therapeutic areas
- Cardiovascular
- Modalities
- Small moleculesPeptides and oligonucleotides are also common for companies in this space, but specific modalities for this company are not detailed
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Shanghai Hongyitang Biopharmaceutical Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Hongyitang Biopharmaceutical Technology.